Business continuity through infection-control measures and the development of products addressing COVID-19
First written in FY2020. 2 of 6 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2024: 1 of 6 companies on the "Worse" side.
5 other companies' latest entry also says "Dropped".
- FY2024DroppedAnnual reportThe business policy and management analysis for the fiscal year under review do not explicitly mention business continuity through infection-control measures or the development of products addressing COVID-19.
- FY2021Restated the development of products addressing COVID-19Annual report
「The Company will also continue to develop products designed with coronavirus countermeasures in mind.」
In addition to business continuity through infection-control measures, the disclosure again explicitly mentions the development of products designed with coronavirus countermeasures in mind. - FY2021-Q3RestatedAnnual report
「Regarding the impact of COVID-19 (hereinafter, the "infection"), the Company regards the safety of its customers, business partners, and employees as its top priority and continues its business activities while implementing infection-control measures.」
The disclosure continues to describe infection-control measures prioritizing the safety of customers, business partners, and employees and business continuity. - FY2021-Q2RestatedAnnual report
「Regarding the impact of COVID-19 (hereinafter, the "infection"), the Company regards the safety of its customers, business partners, and employees as its top priority and continues its business activities while implementing infection-control measures.」
The disclosure continues to describe infection-control measures prioritizing the safety of customers, business partners, and employees and business continuity. - FY2021-Q1Reduced the disclosure to business continuity through infection-control measuresAnnual report
「Regarding the impact of COVID-19 (hereinafter, the "infection"), the Company regards the safety of its customers, business partners, and employees as its top priority and continues its business activities while implementing infection-control measures.」
Infection-control measures prioritizing the safety of customers, business partners, and employees and business continuity are described again, but the development of products addressing COVID-19, which was included for FY2020, is not explicitly mentioned for the current quarter. - FY2020First statedAnnual report
「The Company regards the safety of its customers, business partners, and employees as its top priority and continues its business activities while implementing infection-control measures. In addition, the Company responds promptly and accurately to customers' corrugated cardboard needs and is also developing products designed with COVID-19 countermeasures in mind.」
The disclosure describes infection-control measures prioritizing the safety of customers, business partners, and employees, the continuation of business activities, and the development of products designed with COVID-19 countermeasures in mind as new measures.